Announced
Financials
Tags
Private Equity
Switzerland
pharmaceutical company
Private
Acquisition
Pharmaceuticals
Synopsis
Cooper, a French pharmaceutical company backed by London-based private equity investment firm Charterhouse Capital Partners, acquired Laboratoires Diepharmex, a pharmaceutical company in Geneva, Switzerland. Financial terms were not disclosed. For Cooper, owned by Charterhouse since 2015, this new acquisition grants the opportunity to seize an iconic brand in hygiene and ear care.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.